-
公开(公告)号:US5420135A
公开(公告)日:1995-05-30
申请号:US783101
申请日:1990-12-10
IPC分类号: A61K31/47 , A61P19/10 , A61P43/00 , C07D215/44 , C07D471/04 , C07D513/04 , A61K31/44
CPC分类号: C07D471/04 , C07D215/44 , C07D513/04
摘要: Substituted quinoline derivatives are described as inhibitors bone resorption with in particular, the compound 1-(2-methylphenyl)imidazo[4,5-c]quinoline hydrochloride.
摘要翻译: 化合物1-(2-甲基苯基)咪唑并[4,5-c]喹啉盐酸盐描述了取代的喹啉衍生物作为抑制剂骨吸收。
-
2.
公开(公告)号:US5064833A
公开(公告)日:1991-11-12
申请号:US520561
申请日:1990-05-08
IPC分类号: C07D239/95
CPC分类号: C07D239/95
摘要: 2,4-diaminoquinazoline compounds are inhibitors of the H.sup.+ K.sup.+ ATPase enzyme and useful for the treatment of diseases of the stomach based on excessive gastric acid secretion. A compound of the invention is 2-[2-methyl-4-fluorophenyl)amino]-4-(N-methylphenylamino)quinazoline.
摘要翻译: 2,4-二氨基喹唑啉化合物是H + K + ATP酶的抑制剂,可用于治疗基于过度胃酸分泌的胃疾病。 本发明的化合物是2- [2-甲基-4-氟苯基)氨基] -4-(N-甲基苯基氨基)喹唑啉。
-